Vigilant Capital Management, LLC Astrazeneca PLC Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 418,805 shares of AZN stock, worth $27 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares

418,805

Previous 419,008 0.05%

Holding current value

$27 Million

Previous $29.1 Million 3.06%

% of portfolio

2.24%

Previous 2.36%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $14,191 - $15,389	-203 Reduced 0.05%	418,805 $30 Million
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $533,806 - $605,234	-8,453 Reduced 1.98%	419,008 $29.1 Million
Q4 2022 Jan 26, 2023	SELL	$54.21 - $70.44 $450,051 - $584,792	-8,302 Reduced 1.91%	427,461 $29 Million
Q3 2022 Oct 25, 2022	SELL	$53.02 - $135.75 $148,562 - $380,371	-2,802 Reduced 0.64%	435,763 $23.9 Million
Q2 2022 Jul 06, 2022	SELL	$59.26 - $71.14 $138,549 - $166,325	-2,338 Reduced 0.53%	438,565 $29 Million
Q1 2022 Apr 07, 2022	BUY	$55.72 - $67.12 $537,085 - $646,969	9,639 Added 2.24%	440,903 $29.3 Million
Q4 2021 Jan 06, 2022	BUY	$54.02 - $63.83 $1.62 Million - $1.91 Million	29,955 Added 7.46%	431,264 $25.1 Million
Q3 2021 Oct 08, 2021	BUY	$55.56 - $60.79 $1.6 Million - $1.75 Million	28,781 Added 7.73%	401,309 $24.1 Million
Q2 2021 Jul 09, 2021	BUY	$48.42 - $60.18 $231,931 - $288,262	4,790 Added 1.3%	372,528 $22.3 Million
Q1 2021 Apr 16, 2021	BUY	$47.16 - $54.44 $641,564 - $740,601	13,604 Added 3.84%	367,738 $18.3 Million
Q4 2020 Jan 14, 2021	BUY	$48.52 - $58.02 $610,575 - $730,123	12,584 Added 3.68%	354,134 $17.7 Million
Q3 2020 Oct 15, 2020	BUY	$53.07 - $61.1 $551,131 - $634,523	10,385 Added 3.14%	341,550 $18.7 Million
Q2 2020 Jul 10, 2020	BUY	$43.1 - $55.31 $151,194 - $194,027	3,508 Added 1.07%	331,165 $17.5 Million
Q1 2020 Apr 17, 2020	BUY	$37.79 - $51.33 $418,335 - $568,223	11,070 Added 3.5%	327,657 $14.6 Million
Q4 2019 Jan 17, 2020	SELL	$42.46 - $50.46 $107,211 - $127,411	-2,525 Reduced 0.79%	316,587 $15.8 Million
Q3 2019 Oct 16, 2019	BUY	$40.12 - $45.47 $507,798 - $575,513	12,657 Added 4.13%	319,112 $14.2 Million
Q2 2019 Jul 18, 2019	BUY	$37.28 - $41.68 $987,733 - $1.1 Million	26,495 Added 9.46%	306,455 $12.7 Million
Q1 2019 Apr 09, 2019	BUY	$35.49 - $43.02 $9.91 Million - $12 Million	279,160 Added 34895.0%	279,960 $11.3 Million
Q2 2018 Jul 11, 2018	SELL	$34.55 - $37.05 $7,186 - $7,706	-208 Reduced 20.63%	800 $28,000
Q1 2018 Apr 04, 2018	BUY	$32.97 - $36.63 $6,857 - $7,619	208 Added 26.0%	1,008 $35,000
Q3 2017 Oct 13, 2017	BUY	$28.96 - $34.0 $23,168 - $27,200	800	800 $27,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Astrazeneca PLC Transaction History